Cantor, US
Adam Cantor, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20120269878 | Composition For Transdermal Delivery Of Fentanyl - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 10-25-2012 |
Adam S. Cantor, St. Paul, MN US
Patent application number | Description | Published |
---|---|---|
20100255073 | COMPOSITION FOR TRANSDERMAL DELIVERY OF FENTANYL - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 10-07-2010 |
20110038918 | Composition For Transdermal Delivery of Fentanyl - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 02-17-2011 |
20120034292 | Composition For Transdermal Delivery Of Fentanyl - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 02-09-2012 |
20130064877 | COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 03-14-2013 |
20130295158 | COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 11-07-2013 |
20140170206 | COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 06-19-2014 |
20150025480 | COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL - A transdermal drug delivery composition comprises an acrylate copolymer and from about 8% to about 30% by weight fentanyl. A transdermal fentanyl delivery composition comprising methyl laurate or tetraglycol as a permeation enhancer is also provided. The transdermal drug delivery compositions can be used to make a transdermal drug delivery device for the delivery of fentanyl. | 01-22-2015 |
Adam S. Cantor, River Falls, MN US
Patent application number | Description | Published |
---|---|---|
20110076336 | DRY POWDER PHARMACEUTICAL COMPOSITIONS FOR PULMONARY ADMINISTRATION, AND METHODS OF MANUFACTURING THEREOF - A method of making a dry powder pharmaceutical composition comprising: providing inactive ingredient particles; providing a micronized active ingredient; mixing the inactive ingredient particles with surface-modified nanoparticles to provide an inactive ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and/or mixing the micronized active ingredient with surface-modified nanoparticles to provide a micronized active ingredient comprised of particles having surfaces with the surface-modified nanoparticles deposited on the surfaces; and then mixing the micronized active ingredient with the inactive ingredient; the dry powder compositions made by the method; a use of said composition for the manufacture of a medicament for being delivered to the lungs of a mammal by administering a therapeutic amount of the dry powder pharmaceutical composition, and a dry powder inhalation device comprising a mouth piece, a powder containment system, and the dry powder pharmaceutical composition are disclosed. | 03-31-2011 |
20130006219 | LOW-PROFILE MICRONEEDLE ARRAY APPLICATOR - An applicator used to apply microneedle arrays to a mammal In particular, an application device for applying a microneedle device to a skin surface comprising a flexible sheet having a raised central area attached to the microneedle device and a supporting member at or near the periphery of the flexible sheet, wherein the flexible sheet is configured such that it will undergo a stepwise motion in the direction orthogonal to the major plane of the sheet. | 01-03-2013 |
20140236090 | INTEGRATED MICRONEEDLE ARRAY DELIVERY SYSTEM - The present disclosure provides low-profile systems and methods for delivering a microneedle array. A delivery system includes a housing that may be secured to and temporarily worn on a patient's skin. A carrier assembly coupled to a microneedle array is received in the housing proximate a stored energy device. The stored energy device can be designed to store a predetermined amount of potential energy that is greater or substantially greater than the energy necessary to release said energy. As the stored energy device is potentially capable of releasing substantially more energy than is required to cause the release, the amount of normal force applied to the skin can be minimized while sufficient application velocity is still generated. | 08-21-2014 |
20140243788 | TRANSDERMAL ADHESIVE PATCH ASSEMBLY WITH REMOVABLE MICRONEEDLE ARRAY AND METHOD OF USING SAME - A transdermal adhesive patch assembly and method of using same. The assembly can include a backing, and an adhesive and a matrix coupled to the backing. The matrix can include an active ingredient. The assembly can further include a microneedle array in at least partially overlapping relationship with the matrix; and a carrier that couples the microneedle array to the matrix opposite the backing, wherein the carrier and the microneedle array form a skin treatment assembly that, along with the matrix, can be located on a flap. The method can include adhering at least a portion of the adhesive to skin to form an anchor; applying pressure adjacent the microneedle array to treat an area of the skin; moving the flap away from the skin; removing the skin treatment assembly to expose the matrix; and replacing the flap to position the matrix over the treated area of the skin. | 08-28-2014 |
20140257187 | INTEGRATED MICRONEEDLE ARRAY DELIVERY SYSTEM - The present disclosure provides a low-profile system and methods for delivering a microneedle array. The delivery system includes a housing that may be secured to and temporarily worn on a patient's skin. A carrier assembly coupled to a microneedle array is received in the housing proximate an applicator device. The carrier assembly is at least releasably secured to the housing and it is typically not attached or otherwise fixed to any portion of the applicator device. | 09-11-2014 |
20150246187 | DISPENSING ASSEMBLY - A dispensing assembly for a container filled with a medicinal substance or formulation, the container being suitable for administering the medicinal substance or formulation via inhalation, buccal or sublingual delivery. The dispensing assembly includes a housing ( | 09-03-2015 |
Adam S. Cantor, Saint Paul, MN US
Patent application number | Description | Published |
---|---|---|
20150246187 | DISPENSING ASSEMBLY - A dispensing assembly for a container filled with a medicinal substance or formulation, the container being suitable for administering the medicinal substance or formulation via inhalation, buccal or sublingual delivery. The dispensing assembly includes a housing ( | 09-03-2015 |
Alan Cantor, Ivyland, PA US
Patent application number | Description | Published |
---|---|---|
20100230988 | DUAL STAGE VARIABLE LOAD ENERGY ABSORBER FOR VEHICLE SEATING - A vehicle safety seat system includes a seat, and a frame and support surface that are movable with respect to each other between rest and attenuated positions, wherein the frame and support surface are respectively a first and second distance apart. A biasing mechanism biases the frame and support surface to the rest position between blast and slam down phases. A damper coupled between the frame and support surface has blast and rebound recovery resistance settings. The blast resistance setting is set to a predetermined value based on a weight of a seat occupant. The damper, during the blast phase, resists motion between the frame and support surface toward the attenuated position based upon the blast resistance setting, and after the blast phase and prior to the slam down phase, resists motion between the frame and support surface toward the rest position based upon the rebound recovery resistance setting. | 09-16-2010 |
20100230989 | DUAL STAGE VARIABLE LOAD ENERGY ABSORBER FOR VEHICLE SEATING - A vehicle safety seat system includes a seat, and a frame and support surface that are movable with respect to each other between rest and attenuated positions, wherein the frame and support surface are respectively a first and second distance apart. A biasing mechanism biases the frame and support surface to the rest position between blast and slam down phases. A damper coupled between the frame and support surface has blast and rebound recovery resistance settings. The blast resistance setting is set to a predetermined value based on a weight of a seat occupant. The damper, during the blast phase, resists motion between the frame and support surface toward the attenuated position based upon the blast resistance setting, and after the blast phase and prior to the slam down phase, resists motion between the frame and support surface toward the rest position based upon the rebound recovery resistance setting. | 09-16-2010 |
20140077519 | DUAL STAGE VARIABLE LOAD ENERGY ABSORBER FOR VEHICLE SEATING - A vehicle safety seat system includes a seat, and a frame and support surface that are movable with respect to each other between rest and attenuated positions, wherein the frame and support surface are respectively a first and second distance apart. A biasing mechanism biases the frame and support surface to the rest position between blast and slam down phases. A damper coupled between the frame and support surface has blast and rebound recovery resistance settings. The blast resistance setting is set to a predetermined value based on a weight of a seat occupant. The damper, during the blast phase, resists motion between the frame and support surface toward the attenuated position based upon the blast resistance setting, and after the blast phase and prior to the slam down phase, resists motion between the frame and support surface toward the rest position based upon the rebound recovery resistance setting. | 03-20-2014 |
David Cantor, Alpharetta, GA US
Patent application number | Description | Published |
---|---|---|
20090312663 | System and Method for Neurometric Analysis - A system, comprises a plurality of neurometric analyzing software modules operating on electroencephalogram (EEG) data, each module performing a defined task with respect to neurometric analysis of the EEG data and a database including normative neurometric data in combination with a server including an authorization module, the authorization module comparing data received from a remote user to determine whether the user is authorized to utilize any of the plurality of analyzing software modules and an analysis module configured to receive input data from a patient and select one of the neurometric analyzing modules based on the input data, wherein the selected one of the neurometric analyzing modules compares the input data to the normative neurometric data to generate an output, the analysis module selecting the one of neurometric analyzing modules from a set of subscribed neurometric analyzing modules. | 12-17-2009 |
David Cantor, West Hartford, CT US
Patent application number | Description | Published |
---|---|---|
20080220401 | THERAPEUTIC TOOL AND METHOD FOR USE THEREOF - A therapeutic tool for use with a patient in psychotherapy is provided, the tool includes a central gyroscopic element, a plurality of concentric rings extending around the central gyroscopic element, and a plurality of outer elements removably disposed on the rings and configured to be movable around the rings, wherein the rings are pivotally associated with the gyroscopic ball, and wherein the gyroscopic element is configured to represent a seeing self of the patient and the rings are configured to represent a plurality of subpersonalities of the patient. | 09-11-2008 |
Divya Cantor, Louisville, KY US
Patent application number | Description | Published |
---|---|---|
20090137925 | Impedance Spectroscopy Cervix Scanning Apparatus and Method - In one particular aspect of the present invention, an electrode clip is provided. The clip has a pair of lobes having opposing surfaces, and a stem extending from a side of each of the pair of lobes. A pair of tetra-pole electrodes is provided on each of the opposing surfaces. A resilient connection member joins the stems and is adapted to maintain electrical contact between the pair of tetra-pole electrodes and an actively dilating and effacing cervix. | 05-28-2009 |
20140073879 | SYSTEM FOR MONITORING PREGNANCY IN MAMMALS - A system is disclosed for long term, continuous, monitoring of pregnant mammals particularly to detect the onset of preterm labor. For example, the system enables communication between sensors and a collection unit for transmittal to a remote unit for display and monitoring of the collected data by a clinician while the individual is ambulatory and not in the presence of the clinician. | 03-13-2014 |
Hal C. Cantor, West Bloomfield, MI US
Patent application number | Description | Published |
---|---|---|
20090143761 | AGENT DELIVERY SYSTEM AND USES OF SAME - The use of an automated, controllable, and affixable pulsatile for treating diseases, having an automated controller for controlling the delivery of drug to a patient, an agent delivery reservoir containing an agent operatively connected to the automated controller, a reservoir controller operatively connected to the automated controller and the reservoir for controlling the delivery of agent to a patient, and a feedback control operatively connected to the automated controller for providing feedback with regard to the drug requirements of the patient for use in treating diseases. | 06-04-2009 |
Jacob Cantor, Boca Raton, FL US
Patent application number | Description | Published |
---|---|---|
20140271830 | COMPOSITION AND METHOD FOR GRAY HAIR TREATMENT - A treatment for gray hair is described. The treatment can include a composition for treating gray hair with an active mixture including black trap molasses and vinegar. A standard ratio of vinegar to blackstrap molasses can be at least 1:10. The treatment can also include providing an ingestible hair treatment product including the active mixture and administering a quantity of the hair treatment product to deliver an effective amount of the active mixture. | 09-18-2014 |
Jeffrey B. Cantor, Ft. Lauderdale, FL US
Patent application number | Description | Published |
---|---|---|
20110152754 | Bone graft applicator - Disclosed herein is a bone graft applicator assembly including a specially designed applicator, attached to a reservoir of bone graft material, such that the graft material can be moved into the delivery portion while the tip of the delivery portion is in place. The instantly disclosed device allows for the collapse of the delivery tip so that the tip can be placed between vertebras or alternatively within any bony structure or implant where the placement of bone graft material would be desirable, and then expanded to allow the bone graft material to be placed between the vertebras or the like while maintaining the geometry of the space into which the bone graft material is being placed. | 06-23-2011 |
Jerome Cantor, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20090012012 | Intratracheal administration of endothelin-suppressing agents for the treatment of respiratory disorders - The subject invention is directed to the treatment of respiratory disorders by intratracheal administration of an effective amount of an agent that suppresses the activity of endothelin. Such agents may take the form of: 1) an endothelin-converting enzyme (ECE) inhibitor such as phosphoramidon, or 2) an endothelin receptor antagonist such as bosentan, tezosentan, sitaxsentan, atrasentan, darusentan, clazosentan, or BQ-123. Respiratory disorders include emphysema, asthma, bronchitis, bronchiectasis, pneumonia, adult respiratory distress syndrome, neonatal respiratory distress syndrome, bronchopulmonary dysplasia, interstitial fibrosis, cystic fibrosis, persistent pulmonary hypertension of the newborn, and neoplasia. The treatment is intended for a variety of mammals, such as premature neonates to adult humans. | 01-08-2009 |
Jerome Owen Cantor, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20090143426 | Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments - The invention discloses the composition and preparation of various 1,3,6-trisubstituted-2-carboxy-quinol-4-ones of the formula 1 where R is H, alkyl, haloalkyl or hydroxyalkyl, R′ is alkyl, nitro, halogen or NR | 06-04-2009 |
20140295461 | Method for Determining Lung Injury Using Desmosine and Isodesmosine as Biomarkers - The subject invention is directed to a method for biochemically determining the extent of emphysematous changes in the lung. This method is entirely novel in that it links a biochemical parameter (the ratio of free to peptide-bound desmosine and isodesmosine [DID]) to specific morphological changes in lung tissue consisting of airspace enlargement and rupture of alveolar walls. While the total amount of DID in blood, urine, and sputum have been previously used to measure the rate of breakdown of lung elastic fibers, recent insights using percolation theory, have shown that the ratio of free to peptide-bound DID specifically reflects the total amount of elastic fiber damage in the lung, and is therefore a sensitive measure of emphysematous changes in the lung (which are the direct result of elastic fiber breakdown in alveolar septa). Furthermore, this new method establishes a relatively narrow range of values for normal individuals (without lung disease), which has not been previously possible by measuring total levels of DID (due to their large variability). The technique may be used to determine the amount of pulmonary emphysema in patients with chronic obstructive lung disease, and may also serve as a screening test for healthy smokers and other asymptomatic individuals (e.g. those with alpha-1 antitrypsin deficiency) who are at risk for developing pulmonary emphysema. Early detection of lung elastic fiber injury will result in more timely therapeutic intervention to slow the progression of the disease. | 10-02-2014 |
20150025019 | Method for Dosage Adjustment of Drugs that Prevent Elastic Fiber Breakdown - Elastic fiber damage is responsible for the distention and rupture of alveolar walls in chronic obstructive pulmonary disease (COPD). The current invention comprises a method of adjusting the a dosage of a drug that prevents such elastic fiber damage by employing a feedback loop consisting of measuring the levels of the unique elastic fiber breakdown products, desmosine and isodesmosine in body fluids, preferably sputum. The recent discovery that sputum levels of desmosine and isodesmosine are responsive to treatment with aerosolized hyaluronan in COPD patients makes dosage adjustment both feasible and desirable. This process of dosage adjustment may be applicable to any drug that prevents lung elastic fiber damage, such as alpha-1-antitrypsin, other anti-elastase agents, and antioxidants. It is anticipated that such dosage adjustment will become the “standard of care” in the treatment of COPD patients. | 01-22-2015 |
Louis B. Cantor, Indianapolis, IN US
Patent application number | Description | Published |
---|---|---|
20130046166 | INTRAOCULAR PRESSURE MONITORING SYSTEM - A pressure monitoring system is disclosed. The pressure monitoring system includes a stimulation/response circuit configured to transmit a first signal during a stimulation mode and receive a second signal during a response mode, and a pressure monitoring apparatus configured to receive the first signal and transmit the second signal. The pressure monitoring apparatus includes a capacitive pressure sensor assembly, an insertion needle assembly, and a coil assembly. The insertion needle assembly, having an insertion opening, is coupled to the capacitive pressure sensor assembly, wherein fluid pressure at the insertion opening is fluidly communicated with the capacitive pressure sensor assembly. The coil assembly, having an inductance, is coupled to the capacitive pressure sensor assembly, wherein the coil assembly and the capacitive pressure sensor assembly form a tank circuit with a variable resonant frequency, and wherein the coil assembly receives the first signal and transmits the second signal a time difference later. | 02-21-2013 |
Michael Cantor, New York, NY US
Patent application number | Description | Published |
---|---|---|
20090012928 | System And Method For Generating An Amalgamated Database - A method for creating an amalgamated bioinformatics database from at least a first database and a second database is presented. Concepts are identified in a first field from the records of the first database. A second field from the records of the second database which has data related to the first field is also identified. A first set of concepts is identified by traversing a mediating database using terms associated with the first field and a second set of concepts is also identified by traversing the mediating database using terms associated with the second field. Either the first set of concepts or the second set of concepts, or both, is identified using non-trivial terminological mapping. The set of related concepts in the first set of concepts and the second set of concepts is identified and a record is generated in the amalgamated bioinformatics database. | 01-08-2009 |
Nathaniel David Cantor, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20140191925 | CONFIGURABLE BACKING STRUCTURE FOR A REFLECTOR ANTENNA AND CORRECTIVE SYNTHESIS FOR MECHANICAL ADJUSTMENT THEREOF - A reflector support system is provided that includes a backing structure having a plurality of struts. The backing structure may have a plurality of hubs, each of the plurality of hubs may be configured to couple to two or more of the plurality of struts, each of the plurality of hubs may be configured to couple to another one of the plurality of hubs using one of the plurality of struts, each of the plurality of struts is configured to couple to at least two of the plurality of hubs. The backing structure may have a plurality of feet, each of the plurality of feet configured to couple to a corresponding one of the plurality of hubs, the plurality of feet are configured to couple to a reflector. In addition, a synthesis for mechanical adjustment of the reflector support system is provided. | 07-10-2014 |
Rita Elizabeth Cantor, Gorham, ME US
Patent application number | Description | Published |
---|---|---|
20090007454 | NOZZLE INSERT FOR A YANKEE IMPINGEMENT HOOD - The present invention includes a nozzle insert for use in a drying machine of the type used in paper web drying. The nozzle insert of the present invention includes at least one intake having a central portion, wherein a pair of center vanes is disposed for directing airflow. The central portion is bounded by at least one turning vane adapted for directing airflow in a lateral direction. For each turning vane, there is at least one straightening vane adapted for curtailing swirling of the airflow. The vanes are oriented at optimal angles for directing the flow of the nozzle in a lateral direction, while permitting some air to penetrate the central portion through a series of ports. The intakes are bounded by a series of insulated bulkheads, which serve to direct airflow and contain heat-loss through thermal emission. | 01-08-2009 |
Robin Harold Cantor, Santa Fe, NM US
Patent application number | Description | Published |
---|---|---|
20080277766 | Polymer membranes for microcalorimeter devices - An improved structure for supporting a microcalorimeter device is disclosed. The structure comprises a substrate with superconducting wiring elements disposed on a surface of the substrate. A membrane layer is suspended above the wiring elements and the substrate surface by a tab element, and a microcalorimeter is disposed on top of the membrane layer. The tab and the membrane layer reside in a common plane, and the membrane layer comprises a material that can be applied and cured at low temperatures (e.g. 350 degrees Celsius or less), so as to have minimal affect on the superconductive wiring elements. The in-plane tab/membrane structure has improved reliability when subject to thermal cycling associated with cryogenic temperatures. A method for forming the structure is also disclosed. | 11-13-2008 |
Scott A. Cantor, West Bloomfield, MI US
Patent application number | Description | Published |
---|---|---|
20090143761 | AGENT DELIVERY SYSTEM AND USES OF SAME - The use of an automated, controllable, and affixable pulsatile for treating diseases, having an automated controller for controlling the delivery of drug to a patient, an agent delivery reservoir containing an agent operatively connected to the automated controller, a reservoir controller operatively connected to the automated controller and the reservoir for controlling the delivery of agent to a patient, and a feedback control operatively connected to the automated controller for providing feedback with regard to the drug requirements of the patient for use in treating diseases. | 06-04-2009 |
Stephen M. Cantor, West Hurley, NY US
Patent application number | Description | Published |
---|---|---|
20080235766 | APPARATUS AND METHOD FOR DOCUMENT CERTIFICATION - A method and apparatus for authenticating documents is described. A document from a client is processed to determine if it is authentic and then tags are generated to indicate that a document is authentic or not. The tags can be added to the document before it is sent to a recipient. The document is also stored and made available to the sender, recipient or third party together with a certificate of authenticity. | 09-25-2008 |
Stuart Lawrence Cantor, Mount Airy, MD US
Patent application number | Description | Published |
---|---|---|
20140234406 | NOVEL NANOPARTICULATE SUSPENSION FOR INCORPORATING FAT-SOLUBLE VITAMINS IN THE TREATMENT OF HAIR THINNING and HAIR LOSS - The present invention provides novel compositions comprising a nutritional supplement containing vitamin D-3 (cholecalciferol) and other supporting nutrients (i.e., fat-soluble vitamins A and E) to be administered orally via capsules to human subjects for the prophylaxis and mitigation of hair thinning and hair loss in both men and women. Colloidal silicon dioxide functions to form a nanoparticulate suspension and acts as a viscosifier to thicken the oil(s) used in the capsule filling operation. The colloidal silica contains silicon which acts as a nutrient to help strengthen existing hair, and also functions as a microencapsulation agent, which can incorporate vitamins A and E into its porous structure by sonication. | 08-21-2014 |